Posted by AGORACOM
at 8:25 AM on Tuesday, December 29th, 2020
Adds Mr. Avi Markus, Former General Manager at NRG Innovations and executive at Unilever and Shoppers Drug Mart, as Vice President of Sales for North America
Adds Dr. Kayla Bridges, a Neonatal Dietitian and Milk Room Coordinator at Beaumont Children’s – Royal Oak, as head of U.S. Clinical & Scientific Affairs
ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”)the plant-based baby, toddler and children nutrition company, announces today the expansion of its operational team with the addition of four new members. The new Else team members will help drive North American Retail distribution efforts, medical/health care practitioners’ channels, as well as logistics and Clinical/Scientific Affairs.
“We continue to add experts and professionals, as part of our commitment to growing our presence across North America,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “Having a strong, local team presence will significantly accelerate our mission of bringing clean label, whole food plant-based, sustainable nutrition to families across North America. These talented new team additions will collectively help propel Else forward across key fronts, including sales/marketing, medical channels, logistics, and scientific affairs,” she added.
VP Sales, North America
The Company has hired Mr. Avi Markus, Former General Manager at NRG Innovations LLC, as Vice President of Sales Operations, North America. Mr. Markus has over 18 years of experience in leadership roles at Tier 1 Consumer Goods Companies/Retailers (including Unilever & Shoppers Drug Mart, Canada). He also was a founder and held partnership-level positions at numerous Better-for-You food and beverage companies, including Nourishtea organic tea and Beon Energems. In his role, Mr. Markus will lead North American retail expansion, via brokers, distributors and directly with key retailers.
U.S. Clinical & Scientific Affairs
Dr. Kayla Bridges, DCN, RD-AP, CNSC, FAND, joins the Company as Director of U.S. Clinical & Scientific Affairs. Dr. Bridges is an Advanced Practice Neonatal Dietitian and Milk Room Coordinator at Beaumont Children’s – Royal Oak. Her leadership experience includes 2020 President for the Michigan Chapter of the American Society for Parenteral and Enteral Nutrition (ASPEN), which was named Chapter of the Year under her leadership. She has served on the Clinical Practice Committee for ASPEN, as well as Publications Chair and newsletter Editor for the Academy of Nutrition and Dietetics’ Pediatric Nutrition Practice Group. Dr. Bridges completed her Doctor of Clinical Nutrition degree at Rutgers University and completed her Master of Science with a focus in nutritional biochemistry from West Virginia University. She has received numerous awards and recognition for her work, including the Academy of Nutrition and Dietetics’ Pediatric Nutrition Published Research Award. Dr. Bridges will be instrumental to the development and implementation of clinical trials necessary to obtain key regulatory approvals for Else Nutrition’s ongoing innovation pipeline.
Additional Key Hires
In addition to the above, the Company has added a seasoned Medical Channel Director, with many years of baby nutrition experience, at one of the Top U.S.-based Blue Chip Nutrition Companies. This expert will manage Else Medical Marketing and will promote the brand across the North American Medical Community (Health care practitioners, Pediatricians, Nutritionists, GIs).
A U.S. Logistics Coordinator has also been hired, to streamline logistics and supply, as the Company expands its sales across North America.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Toddler Nutrition was a #1 Best Seller on Amazon in the Baby/Toddler Formula Category in 2020. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Children’s Hospital of Colorado, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM
at 8:19 AM on Tuesday, December 29th, 2020
Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to provide shareholders with this review of the Company’s most successful year ever and thank all shareholders for helping make 2020 the most successful year ever. Moreover, given the partnerships, products, and financing discussed below, Loop Insights is extremely confident that 2021 will see an equal magnitude of growth experienced in 2020.
To this end, Loop Insights CEO Rob Anson stated the following:
Dear shareholders,
2020 was an extraordinary year and we hope you and your families are staying healthy and safe. COVID-19 has had a major impact on economies, families, and businesses. It has been one of Loop’s major focuses to combat the effects of this pandemic in order to help industries recover and thrive in this new normal. Throughout the year, my team and I have worked tirelessly to create products and solutions that would gain the trust of our partners such as Telus, Amazon Web Services, Vend, bdG Sports, and most recently, NTT DATA, so that they could have the confidence necessary to bring this into their global customer opportunities.
I am happy to report that we have accomplished this goal and as a result of these world-class partnerships, are now on the cusp of participating in global opportunities we never thought possible at the beginning of 2020. Moreover, we are very confident that additional significant developments will continue to be announced in 2021 when our partners and customers return from their holiday breaks to resume several high-level discussions across many verticals.
None of these accomplishments in 2020 and those awaiting us in 2021 would be possible without my great team and our great shareholders. I always express gratitude to my team and am especially grateful to the shareholders that have supported Loop this year. Our successes in 2020 have reflected the company’s long-term vision that we continue to execute. As we enjoy this holiday season to spend valuable time with our families, we are also enjoying a much needed but short break before returning to work to further execute on work that awaits us and our partners upon our return. The Loop Insights team has worked hard to achieve a year of incredible successes and looks forward to hitting the ground hungry and humble on behalf of our great shareholders. Thank you so much for your continued support which has been integral to our 2020 success and will be integral to our 2021 success.
2020 CORPORATE DEVELOPMENTS
Loop Insights achieved a number of monumental milestones this calendar year as it developed its leading services including:
AMAZON
On June 8th, Loop Insights was selected to join Amazon Web Services Partner Network, joining the majority of Fortune 100 companies that rely on Amazon’s services every day. As a preferred partner, Loop will seize this networking opportunity to gain access to hundreds of ongoing AWS portfolios, as well as co-development projects. More than 90% of Fortune 100 companies source their solutions and services from Amazon.
On October 22nd, Loop Insights and Amazon Web Services announced the two companies would be hosting an interactive webinar to showcase Loop’s venue tracing capabilities. The webinar was a great success and achieved its maximum attendance of 1,000 viewers, with more than 88% of viewers remaining engaged through to the end of the final Q&A segment. Loop received inquiries from large corporations in sectors such as Airlines, Sports & Entertainment Enterprises, Telecom, and Government, with many significant discussions now at advanced stages.
TELUS
On October 15th, Loop announced the significant milestone of having been accepted into the Telus IoT Marketplace. The Company’s first product accepted into the IoT Marketplace was our contact tracing product, which has received significant exposure to many of TELUS’s largest customers and ongoing significant discussions with them. The third-party validation that came with this acceptance has been instrumental in Loop’s contact tracing discussions with large corporate customers around the world.
On December 3rd, Loop announced the Launch Of A Second Product Into The TELUS IoT Marketplace For National Sales and Marketing To TELUS Business Customers. The Company’s second product accepted into the IoT Marketplace was our Insights service which consists of our IoT Fobi device, Loop Cloud API, and AI Insights Portal that provide automated marketing capabilities. Connected between the printer and point of sale, Loop’s Fobi device’s real-time capabilities are driven by Artificial Intelligence to enhance the shopping experience. Providing data-driven product suggestions and unique discount codes for future use, Loop enables customers to increase revenues through increased spend per customer.
NTT DATA
On December 17th, Loop announced the most significant partnership in its history with NTT DATA, a top-ranked global IoT services company, and subsidiary of Nippon Telegraph and Telephone, the world’s 4th largest telecom company, ranked 55th In Fortune Global 500. As a result of this partnership, Loop will be exposed to global opportunities never thought possible earlier this year. For example, Loop’s successful live deployment of its Venue Bubble solution and its published capabilities with respect to its Travel Bubble solution will be the subject of work on major projects with NTT DATA.
RETAIL – VEND AND SHOPIFY
On August 10th, Loop Insights announced a reseller partnership and API integration with Vend, a leading global PoS company that operates over 25,000 stores across 140 countries. The announcement came with the partnership’s first sale to a franchise with 30 locations. Through the reseller partnership, Loop is working with Vend’s global team to continue to onboard new customers monthly.
On August 20th, Vend and Loop Insights announced a 20-store pilot that successfully concluded on November 4th with an agreement to deploy its insights platform at 550 “Your CBD” locations across 41 states, the largest CBD retailer in the United States. The Your CBD Store win includes the implementation of Loop’s data insights platform across 170 new stores by the end of 2020 and an additional 380 stores in Q2 of 2021.
Loop will significantly benefit from Vend’s large global sales team that is now actively selling Loop’s products and services to its current 25,000 retail customer base, which will provide additional recurring revenue opportunities through monthly SAAS, as well as, potential revenue share opportunities.
In the same announcement on November 4th, Loop announced the completion of its point of sale integration with Shopify, providing Loop with access to the 500,000 merchants currently using the Shopify platform. Completing our Shopify integration further bolsters Loop’s efforts to achieve global scale via e-commerce and bricks and mortar opportunities. Retailers look to leverage data to create personalized shopping experiences across channels and optimize retail supply chain and inventory management. This makes Loop’s real-time online and offline data connectivity vital.
UKLIPZ
On November 12th, Loop announced the 2021 integration of Uklipz into its product stack. This is a very important milestone for Loop due to the significant strength it adds to our offering and the disruption it creates in the massive but problematic consumer review industry. The UKLIPZ platform is another important strategic move by providing our partners and customers with another immediate complimentary plug-in to expand and significantly strengthen the current Loop solution offering. Revenues from UKLIPZ will be generated through multiple streams as follows:
Monthly SaaS fees from Brands and Retailers
Transaction fees when a consumer purchases through the platform
Brands purchasing use of consumer video reviews
Sponsored ads
Retail
WORLD’S FIRST EVER VENUE BUBBLES IN A LIVE ENVIRONMENT
On September 16th, Loop Insights signed an agreement with NCAA Division 1 school, the University of Houston, to implement its contactless venue tracing platform across its facilities. In addition, the school agreed to implement Loop’s contactless, artificial intelligence marketing solutions to provide personalized promotions and targeted engagement at University of Houston football games at TDECU Stadium.
On October 8th Loop announced it was selected as the Premier Venue Tracing and Fan Engagement Solution for NCAA College Basketball #VegasBubble in Las Vegas, where games were played at MGM Grand Garden Arena, Mandalay Bay Events Center, and T-Mobile Arena between November 25 and December 22, 2020.
On November 9th Loop announced it would Implement the First-Ever Fully Integrated “Venue Bubble” (End-To-End Testing, Contact Tracing, and Alert Notifications) at the #BeachBubble NCAA College Basketball Tournament in Fort Myers, Florida, hosting 14 NCAA Division I men’s and women’s basketball teams in November and December that are playing at both Hertz Arena and Alico Arena (FGCU) while lodging at the Hyatt Regency.
On November 23rd, Loop Insights partnered with VenueNext to deliver a seamless mobile commerce solution to both college and professional sports venues across North America. VenueNext was founded in 2014 with Levi’s® Stadium and the San Francisco 49ers and has since gone on to power mobile-first and frictionless commerce in more than one hundred arenas, stadiums, theme parks, universities, corporate cafes, and theaters across the globe.
On December 1st Loop announced achieving 100% success in delivering the first-ever fully integrated “Venue Bubble” in live environments at both NCAA College Basketball Tournaments. Live demonstrations of the Venue Bubbles lead to significant discussions about some of North America’s largest sporting events in 2021 that are set to continue after the holiday break.
EXTENDING VENUE BUBBLES TO FILM AND TRAVEL
On October 19th Loop Insights and Empower Clinics announced the combination of their respective Venue Tracing and COVID-19 testing expertise to create the first-ever “Travel Bubble” solution for the global travel industry. Subsequently, on December 9th Loop and Empower partnered with SimpliFlying, the world’s leading aviation marketing consulting firm, to support specific near-term opportunities with World Renown Resorts, National Tourism Boards, Major Airlines, Airports, Cruise Ships, and Ports.
On December 14th Loop Insights expanded its venue bubble platform to create a “Film bubble”, in partnership with Draganfly’s “Safe Set” solution, for an upcoming major motion picture (“MMP1”) that is scheduled to commence filming in January 2021. The name of the film and the starring actors will remain confidential until the commencement of filming.
HEALTHCARE
On December 8th Loop Insights joined KABN Systems NA Holdings Corp. (CSE:KABN), Liquid Avatar, Lumedic, The Campus Agency, and TripXpertz to form a consortium to manage verifiable identity credentials for COVID-19 vaccinations. Through this consortium and Loop Insights’ previous partnership with iStoc, the Company is now able to provide medical testing beyond the scope of the COVID-19 pandemic.
On December 21st Loop announced the January 2021 launch of its Digital Connect Health Platform, a fully-integrated digital healthcare solution designed for both government and private sector. The launch comes after continuous discussions and requests from government leaders, both Provincial and Federal, over the past 7 months after the April 20 launch of the Beta version of its Smart Health contactless check-in platform, which streamlines patient engagement and operations. Loop’s Smart Health device requires a simple tap of the patient’s mobile phone to check in and verify their ID. Patients have frictionless access to everything they need in one simple wallet pass, including real-time notifications, testing and tracing updates, critical health information, and more.
FINANCING AND INTENTION TO UPLIST TO MAJOR NORTH AMERICAN STOCK EXCHANGES
As a result of our success in 2020 and anticipated success in 2021, Loop announced its “Uplist Plan” on December 7th to begin the process of uplisting to major North American Stock Exchanges. The Uplist Plan outlines Loop’s proposed plan to apply to have its common shares uplisted to the Toronto Stock Exchange (“TSX”), as a technology company, from the TSX Venture Exchange (“TSXV”), followed by an intention to apply for listing on NASDAQ. Completion of the Uplist Plan is subject to meeting certain conditions and approvals that are not assured and outlined in the press release for full review by shareholders.
Moreover, on December 11th, Loop announced the receipt of approximately $4,600,000 from the exercise of warrants up to December 10, 2020. The proceeds from this latest round of warrants being exercised are expected to provide Loop with the financial resources necessary to fund growth and operations to the end of 2021 at a minimum, assuming the Company wasn’t able to generate any further revenue from business operations. As such, the Company does not foresee the need for any financing with the exception of strategic client partners that may want to invest in Loop in order to participate in its growth.
Moreover, as the Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises, the Company is confident it now has the war chest necessary to pursue all anticipated business opportunities as the demand for its solutions continues to grow on a weekly, if not daily basis.
CEO Rob Anson added “As shareholders can see from this year in review, Loop had an incredible year in 2020, and more importantly, is positioned with the right partners, products, pipeline, and financial resources to make the same quantum leap in 2021. Our success is reflective of our hard work and the exceptional quality of our people. Our team has grown and we’ve welcomed many passionate members who continue to drive innovation here at Loop. Despite the challenges created by the COVID-19 pandemic, the Loop team has overcome all obstacles and continues to work to drive the growth of the company, whether working remotely or together in our Vancouver office. We can’t wait to get back to work and deliver more big wins for our shareholders.”
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
Posted by AGORACOM
at 9:04 AM on Thursday, December 24th, 2020
PEAK Provides Update On 2017 Secured Debentures and Exercise of Warrants
Secured debentures issued back in December, 2017, originally totaling $12-million and of which a balance of $3.27-million was still outstanding as on Oct. 1, 2020, have totally been paid back by Peak Fintech Group Inc. or converted into common shares of the company.
The debentures were issued in the course of a private placement financing where the company sold a total of 1,200 units for gross proceeds of $12-million. Each unit sold comprised a $10,000 face value, two-year maturity, 8-per-cent annual interest secured debenture plus 20,000 common share purchase warrants. The maturity was extended by another year in 2019 and the debentures were set to mature on Dec. 16, 2020. Investors who purchased the units could, at any time prior to the maturity date of the debentures, surrender part or all of the amount invested in the debentures to exercise their warrants and purchase common shares of the company at a price of 50 cents per share. In summary, $11.94-million of the debentures was surrendered to exercise warrants and the company paid back $60,000 in cash to investors.
In addition to the warrants exercised as a result of the surrender of the debentures, the company received over $2.5-million in cash from the exercise of warrants unrelated to the debentures between Oct. 1, 2020, and Dec. 23, 2020.
About Peak Fintech Group Inc.
Peak Fintech is the parent company of a group of innovative financial technology (fintech) subsidiaries operating in China’s commercial lending industry. Peak’s subsidiaries use technology, analytics and artificial intelligence to create an ecosystem of lenders, borrowers and other participants in China’s commercial lending space, where lending operations are conducted rapidly, safely, efficiently and with the utmost transparency.
Posted by AGORACOM-JC
at 11:48 AM on Wednesday, December 23rd, 2020
Announced a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators
The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021
TORONTO, ON / December 23, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators. The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021.
“We are very pleased to receive a significant order in our core business with a US manufacturing customer which also includes 2 BioCloud units as part of a package sale,” says Paul Ghezzi, CEO of Kontrol. “Our corporate strategy is to quote BioCloud units as part of all new sales opportunities from our core business. In addition, we are pleased that one of Ontario’s largest Electricity Generators has ordered an initial 2 units of BioCloud. Both customers have additional scale potential with numerous facilities. Our recent product launch and technology walk-through in December was a success and has initiated accelerating interest in how BioCloud can help create safer spaces.”
Distribution Orders
To date the Company has received 40 initial distribution orders for delivery in January from its existing distribution network. The Company has entered into 6 distribution agreements (1 exclusive and 5 non-exclusive) and is in negotiations for various potential additional non-exclusive distributions agreements. Distribution is a key part of our go to market strategy that can allow the Company to scale quickly.
“In a short period of time since the official launch of BioCloud in December we have received strong interest and numerous distribution requests,” says Gary Saunders, VP Kontrol. “We envision many more agreements across the globe as we focus on growing the BioCloud business.”
As the Company continues to build its distribution business, we anticipate that distributors will be required to maintain a minimum of 250-unit sales per annum to retain non-exclusivity and distributor pricing. The Company’s internal goal is to have 30 regional distributors established by the end of Q1 2021.
Customer Pilots
The Company plans to begin numerous pilots with both existing customers of Kontrol and new potential customers. The purpose of the pilots is to provide potential customers with various specific application use cases across their facilities. The types of pilot customers will include the sectors of commercial real-estate, grocery stores, franchised restaurants, educational facilities and other. Subject to pilot customer approval Kontrol may announce customer pilots or may operate them under non-disclosure agreement.
Recurring Revenue
The BioCloud unit operates with a proprietary detection chamber. The retail price for the detection chamber consumable will range from $400 to $500 and the recommended replacement is three times per year or whenever the detection chamber comes into contact with SARS-CoV-2. Customers that purchase multiple units will receive volume discounts for the detection chamber.
Re-Agent Supply Chain
The detection chamber includes a specific re-agent system. To date the Company has been sourcing its re-agents from the United States. The Company has initiated discussions and testing to source its re-agents from Canadian based sources. By doing so it is seeking to add more of its supply chain in Canada but also reduce the costs of the detection chamber. Further updates will be provided following additional testing.
Essential Service
Kontrol and its manufacturing supply chain operate as an Essential Service provider and do not anticipate being impacted by applicable COVID-19 shutdowns.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp. 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 11:34 AM on Wednesday, December 23rd, 2020
Announced that it has closed its previously announced brokered private placement of units of the Company, pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit for aggregate gross proceeds of $1,150,000
The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner
TORONTO, ON / December 23, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has closed its previously announced brokered private placement of units of the Company (the “Units“), pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit (the “Offering Price“) for aggregate gross proceeds of $1,150,000 (the “Offering“). The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner (the “Agent“).
Each Unit is comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant is exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share, for a period of 24 months from the closing of the Offering.
The Company intends to use the net proceeds raised under the Offering for working capital and general corporate purposes.
In connection with the Offering, the Agent received an aggregate cash fee equal to 8.0% of the gross proceeds from the Offering including in respect of any exercise of the Agent’s Option. In addition, on closing the Company granted the Agent non-transferable compensation options (the “Compensation Options“) equal to 8.0% of the total number of Units sold under the Offering (including in respect of any exercise of the Agent’s Option). Each Compensation Option entitles the holder thereof to purchase one Unit at an exercise price equal to the Offering Price for a period of 24 months following the Closing.
In addition, the Company has paid the Agent a financial advisory fee satisfied by the issuance of 830,000 Common Shares.
The securities issued pursuant to the Offering are subject to a four-month and one day hold period under applicable securities laws in Canada.
The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
About KABN North America
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com
KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the proposed use of the net proceeds of the Offering.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
Posted by AGORACOM
at 8:42 AM on Wednesday, December 23rd, 2020
December 23, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company”) is pleased to announce that it has hired Wellington-Dupont Public Affairs (“Wellington-Dupont“) to provide government relations support and lobbying services on behalf of the Company. Wellington-Dupont has approached the Government of Canada in the hopes of initiating first steps for Red Light Holland to receive an exemption for controlled substances use as part of clinical studies, in order to safely analyze the potential positive impacts of psilocybin on mental health.
“We have a big idea. But we need to carefully proceed, in order for it to hopefully come to fruition,” said Red Light Holland CEO and director Todd Shapiro. “This is why we have hired expert lobbying and government relations firm, Wellington Dupont Public Affairs. Through Wellington Dupont, we look forward to engaging the federal government to discuss the usage of natural psilocybin products, and their potential benefits.”
“We are pleased to represent Red Light Holland as they seek an exemption for controlled substances use as part of a clinical study,” said Summer Senter, Consultant Lobbyist at Wellington-Dupont Public Affairs. “Together we are working with another group to build a detailed plan that will lead to potentially ground-breaking and positive change in Canada. We look forward to sharing more news, when appropriate.”
About Wellington Dupont
Wellington Dupont is a North American public affairs firm with strong talent working closely across Canada and the United States. With offices across Canada and the United States, Wellington Dupont’s approach ensures consistent and seamless results throughout all offices while keeping top of mind policy and regulations on both sides of the border.
Wellington Dupont’s team of trusted advisors uses their combined experience in media relations, business, politics, and government to provide sound counsel and strategic advice while helping clients achieve results.
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM-JC
at 7:52 AM on Wednesday, December 23rd, 2020
Expanding from the successful launch in medical-only channels in partnership with Medical Cannabis by Shoppers, Avicanna will now offer RHO Phyto™ nationwide through provincial retailers
RHO Phyto products will include its advanced formulary of sublingual sprays, oil drops and topicals through retail sales channels estimated at $3 billion dollars* in Canada
TORONTO, Dec. 23, 2020 — Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces that the full formulary of RHO Phyto products will be available through retail channels in early 2021 in Canada.
A successful proof of concept and partnership with Medical Cannabis by Shoppers
During the past four months, the RHO Phyto medical formulary has experienced an incredibly successful launch with overwhelming positive support by the medical community including 300 prescribers and 20 clinics. RHO Phyto sales have increased 100%+ month over month in all product categories. The early results show the product formulary key demographics are 55% women, 47% are 51-75 years of age and 90% of consumers are 30+ years old. Avicanna will remain exclusive to Medical Cannabis by Shoppers for medical/prescription use and intends to increase its current commercial SKU’s from 4 to 10 in 2021.
Expansion to retail sales to provide consumers with low barrier access to the same industry leading formulary of medical cannabis products
It has become evident that many consumers who seek cannabis for medical purposes are not going through medical channels, with nearly 44% purchasing from legal storefronts (adult-use). According to the 2020 Canadian Cannabis Survey, 76% of medical cannabis users do not have a medical document – such as a prescription – from a healthcare professional. The ease of access to store-fronts and systemic barriers to connecting with a health care professional who may provide a medical document have continued to impact medical user numbers year over year, which have remained largely the same around 350,000 active registered medical users in Canada since 2018*.
Aras Azadian, Avicanna’s Chief Executive Officer, stated: “The existing stigma around medical cannabis and the barriers to obtain a medical document make it particularly challenging for some patients to access medical cannabis through the appropriate channels with the support of a health care practitioner. We believe that by expanding the RHO Phyto portfolio into retail sales channels we will provide consumers with easier and low barrier access to standardized medical products they seek. For a biopharmaceutical company like Avicanna, this expansion of our medical products into retail channels is in many ways similar to accessing over-the-counter medical products.” Aras Azadian, the companies Chief Executive Officer.
RHO Phyto product attributes and retail sales strategy
The advanced and standardized products are offered in various doses of CBD, THC and THC-Free formulations to provide consumers with a range of inhalation-free cannabinoids-based solutions. The advanced formulations are developed and optimized by Avicanna to provide enhanced absorption versus basic MCT (medium-chain triglyceride) oil formulations while providing a consistent experience with a pleasant taste and smell. The RHO Phyto products are delivered with accurate dosing which also allows for easy titration and dosing by consumers.
Avicanna’s RHO Phyto strategy to leverage retail sales channels is consistent with the company’s vision to provide education and safe delivery of its products through evidenced-based training and education to the consumers, retailers and the medical community. Avicanna aims to establish RHO Phyto as the doctor recommended brand within the cannabis industry and has initiated several pre-clinical and real-world evidence clinical trials on the products with leading Canadian medical institutions.
*source: Statistics Canada
About Avicanna Inc.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura Earth™ or Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all 2 developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (branded as Pura Earth or Pura H&W), medical cannabis (branded as RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the Company to manufacture any of the products, and the ability of the Company to sell any of the products in retail channels in Canada. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 and final short form prospectus dated November 27, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR atwww.sedar.com.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 7:14 AM on Wednesday, December 23rd, 2020
Announced today its plant-based toddler nutrition product will be available for purchase at Sprouts Farmers Market in February 2021
Consumers seeking healthy plant-based alternatives for their toddlers, will soon be able to find ELSE’s complete Toddler Nutrition product in over 360 Sprouts locations nationwide
VANCOUVER, BC , Dec. 23, 2020 /- ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) , a provider of plant-based alternatives to dairy-based baby nutrition, announces today its plant-based toddler nutrition product will be available for purchase at Sprouts Farmers Market in February 2021 .
Consumers seeking healthy plant-based alternatives for their toddlers, will soon be able to find ELSE’s complete Toddler Nutrition product in over 360 Sprouts locations nationwide. The organic formula is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that offers the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients.
“Being on the shelves at Sprouts Farmers Markets is an incredible milestone for our brand,” said Ms. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are appreciative of the belief and support Sprouts has shown in our line of products, as they become the first natural grocery account to distribute Else on a national level. We have our sights set on being highly accessible across the United States , and this will begin with retailers who share our values and exceptionally high standards for progressive nutrition and ‘better-for-you’ foods.”
About Sprouts Farmers Market
True to its farm-stand heritage, Sprouts offers a unique grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products paired with purpose-driven people. The healthy grocer continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based and gluten-free. Headquartered in Phoenix , and one of the fastest growing retailers in the country, Sprouts employs approximately 35,000 team members and operates more than 350 stores in 23 states nationwide.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Toddler Nutrition was a #1 Best Seller on Amazon in the Baby/Toddler Formula Category in 2020. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Children’s Hospital of Colorado , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 7:09 AM on Wednesday, December 23rd, 2020
Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years.
Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
VANCOUVER, BC , Dec. 23, 2020 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables businesses, sports teams and organizations to create instant AR campaigns without a technical background, is pleased to provide investors with a corporate update for calendar 2020, the Company’s best year. Specifically, the Company set records in two key performance indicators (KPI’s):
Total Executed AR Contracts
$775,000 *
Total Proceeds from Financing
$6,000,000 (approximate)
* Approximate Augmented Reality Enterprise, White Label, and SDK contracts
ImagineAR CEO, Alen Paul Silverrstieen said “By every KPI, ImagineAR turned in its best calendar year performance ever. Despite the early negative impact to our sales pipeline as a result of COVID-19 shutting down live events, the pendulum swung quickly as sports teams, corporations and entertainers turned to augmented reality to generate new revenue opportunities through our platform’s ability to create direct mobile engagement and activations. We are very proud of our performance from both a sales and technology development point of view.”
The Company is filing its audited 2020 financials and MD&A for the fiscal year ended August 31, 2020 on SEDAR by the end of this month. Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years. Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
Silverrstieen added “Looking forward into 2021, though COVID-19 was a significant short-term catalyst in 2020, our pipeline clearly indicates it also accelerated the inevitable adoption of AR by 2-3 years, leading to our confident expectation that 2021 will see even greater increases than 2020. We fully expect to deliver news related to new contract wins in early 2021.”
Major New Global Clients
The Company had its best year of augmented reality contracts around the world in 2020.
Five Year White Label Contract with SlapitOnAR, a company owned and operated by true legends in the world of sports in the United States . CEO Mike Vanderjagt , NFL All-Pro Placekicker is the founder and his partners include Johnny Damon (MLB), Mike Modano (NHL), Troy Aikman (NFL), Steve Smith (NBA), and Cobi Jones (MLS).
Five Year White Label Contract with WaV Sports & Entertainment starting with a launch of the NFL Alumni Academy Subscription Mobile App early 2021.
Two Year Partnership with Valencia CF of La Liga in Spain installing the ImagineAR SDK in December 2020 .
Two Year Partnership with Royal Sociedad of La Liga in Spain installing the ImagineAR SDK in February 2021 .
Shoppers Drug Mart White Label Contract for Company-wide Training in 2021.
Business Partnership with India Music Superstar Ananya Birla to Launch ImagineAR for Consumers and Business in India . Ananya music videos have over 350 million views across all social platforms.
North American AR Consumer Campaigns
The Company launched three major consumer AR campaigns in North America .
Jacob “Stitch” Duran Promotion for the Fury vs. Wilder 2 Heavyweight Championship.
In partnership with the Broward Education Foundation, Flo Rida AR Campaign was launched in June 2020 . This AR campaign was covered in the United States by NBC, CBS, NPR, NY Times, Forbes, and many other media publications.
Free Virtual Santa Claus ImagineAR campaign was launched in December 2020 and has been already featured in media including CBS, The Guardian, KTLA, Military Families, and others.
$6,000,000 From Financing & Warrant Redemptions
Confidence in the Company’s augmented reality abilities was also demonstrated by the capital markets with ImagineAR receiving record proceeds from financing in 2020 of approximately $6,000,000 , including approximately $4,500,000 from the exercise of warrants over this summer. As a result, the Company is well financed for growth through to the end of 2021.
HOLIDAY WISHES
The Company wishes its investors in North America and across the world safe and happy holidays.
Most of all, ImagineAR extends its thanks and appreciation to all shareholders for their support and looks forward to achieving even greater things together in 2021.
This News Release is available on the company’s CEO Verified Discusion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
About ImagineAR
ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.
All trademarks of the property of respective owners.
We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward-looking information is based on certain key expectations and assumptions made by Imagination Park’s management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 4:42 PM on Tuesday, December 22nd, 2020
The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.
Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:
COMMERCIALIZATION – The Company’s recreational brand of magic truffles are already being sold in the Netherlands through existing Smart Shops, as well as, its e-commerce platform through microdose packs. To this end, TRIP has already sold its first 100,000 grams of magic truffles months ahead of schedule, and has now increased production by 10X to 1,000,000 grams (not a typo).
TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor. Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.
As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it. The AGORACOM thesis of small cap wealth creation this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!
If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.
